Insulin‑Aspart‑Szjj Suppliers & Bulk Manufacturers

Available Forms: SQ Injection

Available Strengths: 100 units/mL

Reference Brands: NovoLog; Merilog is biosimilar to NovoLog.

Category: Biosimilars

Insulin‑aspart‑szjj is available in SQ Injection and strengths such as 100 units/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Insulin‑aspart‑szjj is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Insulin‑aspart‑szjj can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Merilog is regulated as a biosimilar to NovoLog (insulin aspart) in both the EU and US. In the US, FDA approval involves extensive comparability, safety, and efficacy data in accordance with GMP standards. In the EU, CE marking certifies conformity with MDR standards for biosimilarity, validated through dossiers demonstrating biosimilarity, safety, efficacy, and manufacturing quality. These biosimilars undergo validation, stability testing, and audits, supported by comprehensive documentation including clinical data, safety profiles, and manufacturing practices. For licensing procedures, approved dossiers, and regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to affordable, high-quality insulin biosimilars supporting optimal diabetes management worldwide.